CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113516358
- Phone
- (984) 884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-07 | Rodgers Richard J Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-06-07 | MANUSO JAMES S J Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-06-07 | Benton Susan Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-04-01 | Benton Susan Director | Grant or award | +1,893 | 1,893 | ||
| 2021-04-01 | Rodgers Richard J Director | Grant or award | +2,581 | 26,221 | ||
| 2020-11-19 | MANUSO JAMES S J Director | Purchase | +4,434 | 14,570 | ||
| 2020-11-19 | MANUSO JAMES S J Director | Purchase · Series A Warrant (right to buy) | +6,697 | 6,697 | ||
| 2020-11-19 | MANUSO JAMES S J Director | Purchase · Series B Warrant (right to buy) | +787 | 787 | ||
| 2020-11-19 | Rodgers Richard J Director | Purchase | +17,730 | 23,640 | ||
| 2020-11-19 | Rodgers Richard J Director | Purchase · Series A Warrant (right to buy) | +26,789 | 26,789 | ||
| 2020-11-19 | Rodgers Richard J Director | Purchase · Series B Warrant (right to buy) | +3,148 | 3,148 | ||
| 2020-11-19 | Gallagher Cam Director | Purchase | +8,865 | 23,354 | ||
| 2020-11-19 | Gallagher Cam Director | Purchase · Series A Warrant (right to buy) | +13,394 | 13,394 | ||
| 2020-11-19 | Gallagher Cam Director | Purchase · Series B Warrant (right to buy) | +1,574 | 1,574 | ||
| 2020-11-19 | MEYER ALAN R Director | Purchase | +1,771 | 487,029 | ||
| 2020-11-19 | MEYER ALAN R Director | Purchase · Series A Warrant (right to buy) | +2,679 | 2,679 | ||
| 2020-11-19 | MEYER ALAN R Director | Purchase · Series B Warrant (right to buy) | +315 | 315 | ||
| 2020-11-19 | Ainsworth Sean Director | Purchase | +8,865 | 44,665 | ||
| 2020-11-19 | Ainsworth Sean Director | Purchase · Series A Warrant (right to buy) | +13,394 | 13,394 | ||
| 2020-11-19 | Ainsworth Sean Director | Purchase · Series B Warrant (right to buy) | +1,574 | 1,574 |
Page 12 of 15 · 283 trades